Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; this is a minor version change with no alterations to study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded new study locations (California and several states) and updated to revision v3.3.3, replacing the previous location groupings.SummaryDifference0.7%

- Check53 days agoChange DetectedThe page shows a revision update from v3.3.1 to v3.3.2, indicating a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check60 days agoChange DetectedMinor UI change updating the page revision from v3.2.0 to v3.3.1 at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check67 days agoChange DetectedFunding/operating status banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedNo significant changes detected between the two screenshots; the page content appears unchanged.SummaryDifference0.3%

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.